Optical coherence evaluation of everolimus-eluting stents 8 months after implantation

Heart

Volumn 97, Issue 17, 2011, Pages 1379-1384

  Inoue, Takumi ^a   Shite, Junya ^a   Yoon, Junghan ^b   Shinke, Toshiro ^a   Otake, Hiromasa ^a   Sawada, Takahiro ^a   Kawamori, Hiroyuki ^a   Katoh, Hiroki ^a   Miyoshi, Naoki ^a   Yoshino, Naoki ^a   Kozuki, Amane ^a   Hariki, Hirotoshi ^a   Hirata, Ken Ichi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Yonsei University Wonju   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CILOSTAZOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EVEROLIMUS; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOSORBIDE MONONITRATE; NICORANDIL;

AGED; ARTERY LESION; ARTICLE; CORONARY STENT; DRUG ELUTING STENT; FEMALE; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; NEOINTIMA; NEOINTIMA THICKNESS; OBSERVATIONAL STUDY; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; STENT; STENT STRUT; STENT THROMBOSIS; THICKNESS; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; NEOINTIMA; SIROLIMUS; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 80051552401     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.204339     Document Type: Article

References (23)

1. Stone GW, Midei M, Newman W, et al. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial. JAMA 2008;299:1903-13. (Pubitemid 351574920)
2. Stone GW, Midei M, Newman W, et al. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents two-year clinical follow-up from the clinical evaluation of the Xience V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions: (SPIRIT) III Trial. Circulation 2009;119:680-6.
3. Kedhi E, Joesoef KS, McFadden E, et al. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomized trial. Lancet 2010;375:201-9.
4. Torguson R, Waksman R. Overview of the 2007 food and drug administration circulatory system devices panel meeting on the Xience V everolimus-eluting coronary stent. Am J Cardiol 2008;102:1624-30.
5. Jang IK, Bouma BE, Kang DH, et al. Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. J Am Coll Cardiol 2002;39:604-9.
6. Matsumoto D, Shite J, Shinke T, et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J 2007;28:961-7. (Pubitemid 47343895)
7. Yamaguchi T, Terashima M, Akasaka T, et al. Safety and feasibility of an intravascular optical coherence tomography image wire system in the clinical setting. Am J Cardiol 2008;101:562-7. (Pubitemid 351625080)
8. Kataiwa H, Tanaka A, Kitabata H, et al. Safety and usefulness of non-occlusion image acquisition technique for optical coherence tomography. Circ J 2008;72:1536-7.
9. Tanigawa J, Barlis P, Mario CD, et al. Intravascular optical coherence tomography: optimization of image acquisition and quantitative assessment of stent strut apposition. EuroIntervention 2007;3:128-36.
10. Sawada T, Shite J, Negi N, et al. Factors that influence measurements and accurate evaluation of stent apposition by optical coherence tomography. Assessment using a phantom model. Circ J 2009;73:1841-7.
11. Jang IK, Tearney GJ, MacNeill B, et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation 2005;111:1551-5. (Pubitemid 40470652)
12. Kume T, Akasaka T, Kawamoto T, et al. Assessment of coronary arterial thrombus by optical coherence tomography. Am J Cardiol 2006;97:1713-17. (Pubitemid 43817856)
13. Miyoshi N, Shite J, Shinke T, et al. Comparison by optical coherence tomography of paclitaxel-eluting stents with sirolimus-eluting stents implanted in one coronary artery in one procedure. Circ J 2010;74:903-8.
14. Tanigawa J, Barlis P, Mario CD, et al. The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography. Int J Cardiol 2009;134:180-8.
15. James SF, Michael F, Richard H, et al. A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. J Am Coll Cardiol 1991;17:758-69.
16. Teramoto T, Ikeno F, Otake H, et al. Intriguing peri-strut low-intensity area detected by optical coherence tomography after coronary stent deployment. Circ J 2010;74:1257-9.
17. Wilson GJ, Nakazawa G, Schwartz RS, et al. Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries. Circulation 2009;120:141-9.
18. Finn AV, Kolodgie FD, Harnek J, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus and paclitaxel eluting stents. Circulation 2005;112:270-8. (Pubitemid 40982311)
19. Hara H, Nakamura M, Palmaz JC, et al. Role of stent design and coatings on restenosis and thrombosis: advanced drug delivery reviews. Adv Drug Deliv Rev 2006;58:377-86. (Pubitemid 43816740)
20. Otake H, Shite J, Ako J, et al. Local determinants of thrombus formation following sirolimus-eluting stent implantation assessed by optical coherence tomography. JACC Cardiovasc Interv 2009;2:459-66.
21. Farb A, Burke AP, Kolodgie FD, et al. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 2003;108:1701-6. (Pubitemid 37243657)
22. Finn AV, Joner M, Nakazawa G, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 2007;115:2435-41. (Pubitemid 46717966)
23. Stone GW, Rizvi A, Newman W, et al. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. N Engl J Med 2010;362:1663-74.